153 related articles for article (PubMed ID: 37087632)
1. [Advances on pentraxin 3 in osteoporosis and fracture healing].
Lu JJ; Sun Y; Zhang X; Wang QQ; Xiang ZY; Ling YQ; Tong PJ; Xu TT
Zhongguo Gu Shang; 2023 Apr; 36(4):393-8. PubMed ID: 37087632
[TBL] [Abstract][Full Text] [Related]
2. MiR-1224-5p modulates osteogenesis by coordinating osteoblast/osteoclast differentiation via the Rap1 signaling target ADCY2.
Hu L; Xie X; Xue H; Wang T; Panayi AC; Lin Z; Xiong Y; Cao F; Yan C; Chen L; Cheng P; Zha K; Sun Y; Liu G; Yu C; Hu Y; Tao R; Zhou W; Mi B; Liu G
Exp Mol Med; 2022 Jul; 54(7):961-972. PubMed ID: 35831436
[TBL] [Abstract][Full Text] [Related]
3. Genetic Deficiency of the Long Pentraxin 3 Affects Osteogenesis and Osteoclastogenesis in Homeostatic and Inflammatory Conditions.
Granata V; Strina D; Schiavone ML; Bottazzi B; Mantovani A; Inforzato A; Sobacchi C
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068970
[TBL] [Abstract][Full Text] [Related]
4. Psoralen accelerates bone fracture healing by activating both osteoclasts and osteoblasts.
Zhang T; Han W; Zhao K; Yang W; Lu X; Jia Y; Qin A; Qian Y
FASEB J; 2019 Apr; 33(4):5399-5410. PubMed ID: 30702934
[TBL] [Abstract][Full Text] [Related]
5. The Long Pentraxin 3 Plays a Role in Bone Turnover and Repair.
Grčević D; Sironi M; Valentino S; Deban L; Cvija H; Inforzato A; Kovačić N; Katavić V; Kelava T; Kalajzić I; Mantovani A; Bottazzi B
Front Immunol; 2018; 9():417. PubMed ID: 29556234
[TBL] [Abstract][Full Text] [Related]
6. PTX3 stimulates osteoclastogenesis by increasing osteoblast RANKL production.
Lee EJ; Song DH; Kim YJ; Choi B; Chung YH; Kim SM; Koh JM; Yoon SY; Song Y; Kang SW; Chang EJ
J Cell Physiol; 2014 Nov; 229(11):1744-52. PubMed ID: 24664887
[TBL] [Abstract][Full Text] [Related]
7. Advances in the roles of ATF4 in osteoporosis.
Xiao Y; Xie X; Chen Z; Yin G; Kong W; Zhou J
Biomed Pharmacother; 2023 Dec; 169():115864. PubMed ID: 37948991
[TBL] [Abstract][Full Text] [Related]
8. Impairment of PTX3 expression in osteoblasts: a key element for osteoporosis.
Scimeca M; Salustri A; Bonanno E; Nardozi D; Rao C; Piccirilli E; Feola M; Tancredi V; Rinaldi A; Iolascon G; Orlandi A; Gasbarra E; Maffulli N; Brandi ML; Tarantino U
Cell Death Dis; 2017 Oct; 8(10):e3125. PubMed ID: 29022895
[TBL] [Abstract][Full Text] [Related]
9. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
[TBL] [Abstract][Full Text] [Related]
10. Surfactin suppresses osteoclastogenesis via the NF-κB signaling pathway, promotes osteogenic differentiation in vitro, and inhibits oestrogen deficiency-induced bone loss in vivo.
Kuang Z; Yang X; Cao Z; Li Y; Hu J; Hong X; Li B; Wu C; Qi Q; Liu X; Dai M
Int Immunopharmacol; 2023 Apr; 117():109884. PubMed ID: 36805201
[TBL] [Abstract][Full Text] [Related]
11. Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing.
Bergdolt S; Kovtun A; Hägele Y; Liedert A; Schinke T; Amling M; Huber-Lang M; Ignatius A
PLoS One; 2017; 12(6):e0179512. PubMed ID: 28614388
[TBL] [Abstract][Full Text] [Related]
12. Pentraxin 3 promotes the osteoblastic differentiation of MC3T3-E1 cells through the PI3K/Akt signaling pathway.
Liu Y; Wang H; Zhou XZ; Li N; Guo YC; Chen TP
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32436939
[TBL] [Abstract][Full Text] [Related]
13. AS-605240 Blunts Osteoporosis by Inhibition of Bone Resorption.
Sun J; Cai G; Shen J; Cheng P; Zhang J; Jiang D; Xu X; Lu F; Chen L; Chen H
Drug Des Devel Ther; 2023; 17():1275-1288. PubMed ID: 37138583
[TBL] [Abstract][Full Text] [Related]
14. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
[TBL] [Abstract][Full Text] [Related]
15. Endogenous parathyroid hormone (PTH) signals through osteoblasts via RANKL during fracture healing to affect osteoclasts.
Sun P; Wang M; Yin GY
Biochem Biophys Res Commun; 2020 May; 525(4):850-856. PubMed ID: 32169280
[TBL] [Abstract][Full Text] [Related]
16. [Regulatory function and mechanism of autophagy on osteoclast].
Miao JS; Wang XY; Jin HM
Zhongguo Gu Shang; 2023 Apr; 36(4):357-63. PubMed ID: 37087626
[TBL] [Abstract][Full Text] [Related]
17. Up-regulated CST5 inhibits bone resorption and activation of osteoclasts in rat models of osteoporosis via suppression of the NF-κB pathway.
Wang F; Zhang C; Ge W; Zhang G
J Cell Mol Med; 2019 Oct; 23(10):6744-6754. PubMed ID: 31402549
[TBL] [Abstract][Full Text] [Related]
18. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
[TBL] [Abstract][Full Text] [Related]
19. The calcium channel TRPV6 is a novel regulator of RANKL-induced osteoclastic differentiation and bone absorption activity through the IGF-PI3K-AKT pathway.
Ma J; Zhu L; Zhou Z; Song T; Yang L; Yan X; Chen A; Ye TW
Cell Prolif; 2021 Jan; 54(1):e12955. PubMed ID: 33159483
[TBL] [Abstract][Full Text] [Related]
20. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.
Zhao C; Sun W; Zhang P; Ling S; Li Y; Zhao D; Peng J; Wang A; Li Q; Song J; Wang C; Xu X; Xu Z; Zhong G; Han B; Chang YZ; Li Y
RNA Biol; 2015; 12(3):343-53. PubMed ID: 25826666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
